These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15864139)

  • 21. Practice of CYP450 genotyping and phenotyping in children in a real-life setting.
    Rodieux F; Daali Y; Rollason V; Samer CF; Ing Lorenzini K
    Front Pharmacol; 2023; 14():1130100. PubMed ID: 36937881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
    de Leon J; Susce MT; Murray-Carmichael E
    Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase.
    Weinshilboum RM; Otterness DM; Szumlanski CL
    Annu Rev Pharmacol Toxicol; 1999; 39():19-52. PubMed ID: 10331075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function.
    Stingl JC; Brockmöller J; Viviani R
    Mol Psychiatry; 2013 Mar; 18(3):273-87. PubMed ID: 22565785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacoeconomic analyses of azathioprine, methotrexate and prospective pharmacogenetic testing for the management of inflammatory bowel disease.
    Priest VL; Begg EJ; Gardiner SJ; Frampton CM; Gearry RB; Barclay ML; Clark DW; Hansen P
    Pharmacoeconomics; 2006; 24(8):767-81. PubMed ID: 16898847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations-Where to from Here for Global Precision Medicine?
    de Andrés F; Sosa-Macías M; Ramos BPL; Naranjo MG; LLerena A
    OMICS; 2017 Sep; 21(9):509-519. PubMed ID: 28873029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics: a laboratory tool for optimizing therapeutic efficiency.
    Linder MW; Prough RA; Valdes R
    Clin Chem; 1997 Feb; 43(2):254-66. PubMed ID: 9023127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.
    Céspedes-Garro C; Naranjo MG; Rodrigues-Soares F; LLerena A; Duconge J; Montané-Jaime LK; Roblejo H; Fariñas H; Campos ML; Ramírez R; Serrano V; Villagrán CI; Peñas-LLedó EM
    Pharmacogenomics; 2016 Oct; 17(15):1707-1724. PubMed ID: 27633613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacogenetic testing: utility in drug development and in routine clinical practice].
    Jaillon P
    Bull Acad Natl Med; 2006 Jan; 190(1):25-34; discussion 34-6. PubMed ID: 16878444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phenotyping of enzymes participating in drug metabolism].
    Svatopluk S; Karolína H; Ondřej S
    Ceska Slov Farm; 2012 Jun; 61(3):115-26. PubMed ID: 22913827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients.
    Mas S; Gassó P; Torra M; Bioque M; Lobo A; González-Pinto A; Olmeda MS; Corripio I; Vieta E; Castro-Fornieles J; Rodriguez-Jimenez R; Bobes J; Usall J; Llerena A; Saiz-Ruiz J; Bernardo M; Lafuente A; PEPs Group
    Eur Neuropsychopharmacol; 2017 Jul; 27(7):647-656. PubMed ID: 28389049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
    Ruano G; Kost JA
    Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. To Genotype or Phenotype for Personalized Medicine? CYP450 Drug Metabolizing Enzyme Genotype-Phenotype Concordance and Discordance in the Ecuadorian Population.
    De Andrés F; Terán S; Hernández F; Terán E; LLerena A
    OMICS; 2016 Dec; 20(12):699-710. PubMed ID: 27849442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP2D6 genotyping for psychiatric patients treated with risperidone: considerations for cost-effectiveness studies.
    Rodríguez-Antona C; Gurwitz D; de Leon J; Llerena A; Kirchheiner J; de Mesa EG; Ibarreta D
    Pharmacogenomics; 2009 Apr; 10(4):685-99. PubMed ID: 19374522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
    Hafner S; Haubensak S; Paul T; Zolk O
    Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
    Bosch TM
    Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness.
    Linares OA; Daly D; Linares AD; Stefanovski D; Boston RC
    Pain Med; 2014 May; 15(5):791-806. PubMed ID: 24517173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.
    Sim SC; Kacevska M; Ingelman-Sundberg M
    Pharmacogenomics J; 2013 Feb; 13(1):1-11. PubMed ID: 23089672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
    Oscarson M
    Clin Chem Lab Med; 2003 Apr; 41(4):573-80. PubMed ID: 12747605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe.
    van den Akker-van Marle ME; Gurwitz D; Detmar SB; Enzing CM; Hopkins MM; Gutierrez de Mesa E; Ibarreta D
    Pharmacogenomics; 2006 Jul; 7(5):783-92. PubMed ID: 16886902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.